Sight Sciences gets Medicare pricing for TearCare from Novitas and FCSO; $1,141.59 fee

Sight Sciences, Inc.

Two MACs set jurisdiction-wide pricing for CPT 0563T (TearCare) at $1,141.59, effective Jan 1, 2025.
Covers 10.4M estimated Medicare lives (~30% of FFS beneficiaries) across multiple states.
Company plans to provide updated revenue and adjusted opex guidance on Q3 2025 earnings call.
Sight Access Portal launched to assist providers with benefit verifications and prior authorizations.

item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.